Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)
Titel:
Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)
Auteur:
Mueller, Volkmar Wardley, Andrew Paplomata, Elisavet Hamilton, Erika Zelnak, Amelia Fehrenbacher, Louis Jakobsen, Erik Curtit, Elsa Boyle, Frances Harder Brix, Eva Brenner, Andrew Crouzet, Laurence Ferrario, Cristiano Muñoz-Mateu, Montserrat Arkenau, Hendrik-Tobias Iqbal, Nayyer Aithal, Sramila Block, Margaret Cold, Soeren Cancel, Mathilde Hahn, Olwen Poosarla, Teja Stringer-Reasor, Erica Colleoni, Marco Cameron, David Curigliano, Giuseppe Siadak, Muriel DeBusk, Kendra Ramos, Jorge Feng, Wentao Gelmon, Karen